Search Results - "Bojková, Denisa"

Refine Results
  1. 1

    Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery by Riedl, André, Bojková, Denisa, Tan, Jiang, Jeney, Ábris, Larsen, Pia-Katharina, Jeney, Csaba, Full, Florian, Kalinke, Ulrich, Ruzsics, Zsolt

    Published in Vaccines (Basel) (01-07-2024)
    “…We investigated the basic characteristics of a new murine cytomegalovirus (MCMV) vector platform. Using BAC technology, we engineered replication-competent…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Proteomics of SARS-CoV-2-infected host cells reveals therapy targets by Bojkova, Denisa, Klann, Kevin, Koch, Benjamin, Widera, Marek, Krause, David, Ciesek, Sandra, Cinatl, Jindrich, Münch, Christian

    Published in Nature (London) (16-07-2020)
    “…A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes…”
    Get full text
    Journal Article
  4. 4

    Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication by Klann, Kevin, Bojkova, Denisa, Tascher, Georg, Ciesek, Sandra, Münch, Christian, Cinatl, Jindrich

    Published in Molecular cell (01-10-2020)
    “…SARS-CoV-2 infections are rapidly spreading around the globe. The rapid development of therapies is of major importance. However, our lack of understanding of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Lack of antiviral activity of darunavir against SARS-CoV-2 by De Meyer, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Van Damme, Ellen, Buyck, Christophe, Van Loock, Marnix, Woodfall, Brian, Ciesek, Sandra

    “…•Darunavir showed no in vitro antiviral activity against SARS-CoV-2 (EC50 > 100 μM).•Remdesivir demonstrated potent antiviral activity, confirming validity of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection by Ellinger, Bernhard, Bojkova, Denisa, Zaliani, Andrea, Cinatl, Jindrich, Claussen, Carsten, Westhaus, Sandra, Keminer, Oliver, Reinshagen, Jeanette, Kuzikov, Maria, Wolf, Markus, Geisslinger, Gerd, Gribbon, Philip, Ciesek, Sandra

    Published in Scientific data (26-02-2021)
    “…SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, in which acute respiratory infections are associated with high socio-economic burden…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs by Toptan, Tuna, Hoehl, Sebastian, Westhaus, Sandra, Bojkova, Denisa, Berger, Annemarie, Rotter, Björn, Hoffmeier, Klaus, Cinatl, Jr, Jindrich, Ciesek, Sandra, Widera, Marek

    “…The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings by Widera, Marek, Westhaus, Sandra, Rabenau, Holger F., Hoehl, Sebastian, Bojkova, Denisa, Cinatl, Jindrich, Ciesek, Sandra

    Published in Medical microbiology and immunology (01-08-2021)
    “…The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread…”
    Get full text
    Journal Article
  15. 15

    SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach by Layer, Emily, Hoehl, Sebastian, Widera, Marek, Bojkova, Denisa, Westphal, Tim, Gottschalk, Rene, Boeddinghaus, Boris, Schork, Joscha, Ciesek, Sandra, Goetsch, Udo

    “…•International travel enables the spread of SARS-CoV-2 and its viral variants•The antigen test showed a sensitivity of 100% with respect to in vitro…”
    Get full text
    Journal Article
  16. 16

    Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells by Schäfer, Richard, Spohn, Gabriele, Bechtel, Marco, Bojkova, Denisa, Baer, Patrick C., Kuçi, Selim, Seifried, Erhard, Ciesek, Sandra, Cinatl, Jindrich

    Published in Stem cell reports (09-03-2021)
    “…Previous studies reported on the safety and applicability of mesenchymal stem/stromal cells (MSCs) to ameliorate pulmonary inflammation in acute respiratory…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Aprotinin Inhibits SARS-CoV-2 Replication by Bojkova, Denisa, Bechtel, Marco, McLaughlin, Katie-May, McGreig, Jake E, Klann, Kevin, Bellinghausen, Carla, Rohde, Gernot, Jonigk, Danny, Braubach, Peter, Ciesek, Sandra, Münch, Christian, Wass, Mark N, Michaelis, Martin, Cinatl, Jr, Jindrich

    Published in Cells (Basel, Switzerland) (30-10-2020)
    “…Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under…”
    Get full text
    Journal Article
  19. 19

    USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING by Karlowitz, Rebekka, Stanifer, Megan L., Roedig, Jens, Andrieux, Geoffroy, Bojkova, Denisa, Bechtel, Marco, Smith, Sonja, Kowald, Lisa, Schubert, Ralf, Boerries, Melanie, Cinatl, Jindrich, Boulant, Steeve, van Wijk, Sjoerd J. L.

    Published in Cell death & disease (06-08-2022)
    “…Pattern recognition receptors (PRRs) and interferons (IFNs) serve as essential antiviral defense against SARS-CoV-2, the causative agent of the COVID-19…”
    Get full text
    Journal Article
  20. 20

    Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy by Bojkova, Denisa, Costa, Rui, Reus, Philipp, Bechtel, Marco, Jaboreck, Mark-Christian, Olmer, Ruth, Martin, Ulrich, Ciesek, Sandra, Michaelis, Martin, Cinatl, Jindrich

    Published in Metabolites (13-10-2021)
    “…SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of…”
    Get full text
    Journal Article